Close Menu

News & Resources

Stelis Biopharma strengthens its Board with experienced industry leadership and diversity

Read more

Stelis Biopharma appoints Mark W. Womack as the new CEO

Read more

TLC and Strides partner to launch Liposomal Amphotericin B in India

Read more

Stelis concludes US$ 195m Series B and Series C fund raise

Read more

RDIF and Stelis Biopharma partner to supply 200 million doses of the Sputnik V vaccine

Read more

A Global CDMO in the Making

Read more

Strides Board Approves Incremental Investments in Stelis

Read more